Clinical Trial Update: Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of patiromer in Chinese subjects has completed, assessing its efficacy and safety for hyperkalemia in the setti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperkalemia

Drugs mentioned

• Patiromer (patiromer)

Snippet

Sponsor: Vifor Fresenius Medical Care Renal Pharma | Conditions: Hyperkalemia, Renal Insufficiency, Chronic | Phase 3 | Status: COMPLETED